Drug use among the home-dwelling elderly

Trends, polypharmacy, and sedation

Tarja Linjakumpu

Department of Psychiatry, University of Oulu
Härkätie Health Center
Institute of Clinical Medicine, General Practice, University of Turku

Abstract

The elderly use drugs more commonly than younger persons. Many studies about drug use have concentrated on institutionalized elders. Knowledge of drug use by the oldest old, aged 85 years or over, is scant. Psychotropics are among the drugs most commonly used by the elderly. Psychotropics have many adverse effects, such as balance impairment, sedation, reduced cognition, depression, and extrapyramidal symptoms. We do not know the extent of sedative drug use, including psychotropics and drugs prescribed for somatic disorders that have sedative properties. Withdrawal of unnecessary drugs appears to be beneficial and to improve the functional capacities of the elderly.

The aim of this study was to describe the changes in prescription drug use, polypharmacy, and psychotropic use among home-dwelling elderly Finns in the 1990s by using two cross-sectional community surveys. The specific aim was to classify all drugs used in Finland into four groups based on their sedative properties.

Drug use, polypharmacy, and, to some extent, psychotropic use increased within a decade. The oldest old used prescription drugs most commonly. Polypharmacy was independently associated with higher age, and in 1998-99, with at least 3 chronic diseases, poor self-perceived health, and the use of home nursing services. Most psychotropic users were on regular medication. The use of hypnotics and antidepressants increased most. Persons with polypharmacy used significantly more commonly psychotropics compared to other people. Over 84-year-olds used psychotropics more commonly than younger persons.

Sedative use was common, as 40 % of drug users used them. Sedative use was significantly more common among persons with polypharmacy than others. According to logistic regression models, the use of many sedatives was independently associated with age 80 years or over, female gender, chronic morbidity, smoking, poor self-perceived health/life satisfaction, and the use of home nursing. Both polypharmacy and abundant sedative use were associated with impaired physical functional abilities.

Prescribers need to be aware of the increasing polypharmacy and abundant sedative use. Regular assessment of indications is needed to avoid overuse of drugs. Geriatric knowledge is needed to support health centers and specialized units in this demanding task.


Dedication

To my parents

Table of Contents
Acknowledgements
Abbreviations
List of original papers
1. Introduction
2. Review of the literature
2.1. Aging and health
2.1.1. Definition of aging
2.1.2. Aging and somatic morbidity
2.1.3. Aging and mental disorders
2.1.4. Pharmacokinetics and pharmacodynamics of drugs and aging
2.2. Drug use in the elderly
2.2.1. History
2.2.2. Drug use in general
2.2.3. Polypharmacy
2.2.4. Psychotropic use
2.2.5. Polypharmacy of psychotropics
2.2.6. Sedation
2.2.7. Adverse effects of drugs
2.2.8. Physical functional abilities connected with medications
3. Aims of the study
4. Materials and methods
4.1. Study design and populations
4.1.1. Background data of participants
4.2. Study protocol
4.2.1. Ethics
4.3. Data collection and the Anatomical Therapeutic Chemical (ATC) classification system
4.4. Use of official registers
4.5. Definitions
4.6. Statistical methods
5. Results
5.1. Drug use and polypharmacy (I)
5.1.1. Medication use in general
5.1.2. Polypharmacy
5.2. Psychotropic use (II)
5.2.1. Comparison of national and community prescription data
5.2.2. Psychotropic use in general
5.2.3. Concomitant use of psychotropics
5.2.4. Psychotropic use and the young elderly
5.3. Classification of drugs by their sedative properties (III)
5.3.1. Application of the classification in community
5.4. Items connected with sedative drug use (IV)
6. Discussion
6.1. Study population, strengths and limitations of the study
6.2. Data and data collection
6.3. Definitions
6.4. Drug use (I)
6.5. Polypharmacy (I)
6.6. Factors associated with polypharmacy
6.7. Psychotropic use (II)
6.8. Classification of drugs by their sedative properties (III)
6.9. Items connected with sedative drug use (IV)
7. Conclusions
References
A. Appendix tables 1-2
List of Tables
1. Prescription drug use by the home-dwelling elderly according to different studies with special reference to the oldest population.
2. Prescription psychotropic use by the home-dwelling elderly according to different studies with special reference to the oldest population.
3a. Sociodemographic and other characteristics of the home-dwelling elderly by the number of drugs used in community in 1990–91 and 1998–99.
3b. Sociodemographic and other characteristics of home-dwelling elderly men by the number of drugs used in community in 1990–91 and 1998–99.
3c. Sociodemographic and other characteristics of home-dwelling elderly women by the number of drugs used in community in 1990–91 and 1998–99.
4a. Distribution of male home-dwelling elderly prescription drug users in 1990–91 and 1998–99 by age and number of medicines with special reference to the risk (OR) to have polypharmacy (> 5 drugs) as a function of time.
4b. Distribution of female home-dwelling elderly prescription drug users in 1990–91 and 1998–99 by age and number of medicines with special reference to the risk (OR) to have polypharmacy (> 5 drugs) as a function of time.
5a. Distribution of home-dwelling elderly prescription drug users in 1990–91 by age and number of medicines with special reference to the risk (OR) of polypharmacy (> 5 drugs) among women compared to men.
5b. Distribution of home-dwelling elderly prescription drug users in 1998–99 by age and number of medicines with special reference to the risk (OR) of polypharmacy (> 5 drugs) among women compared to men.
6. The most essential variables, adjusted odds ratios (OR), and 95% confidence intervals (CI) predicting the probability of polypharmacy among the home-dwelling elderly in 1990–91 and 1998–99.
7. Proportions (%) of home-dwelling elderly psychotropic users and regular use by them in 1990–91 and 1998–99 by age.
8. The most essential variables, adjusted odds ratios (OR), and 95% confidence intervals (CI) predicting the probability of polysedation among the home-dwelling elderly.
1. Examples of adverse effects and symptoms associated with medications prescribed for the elderly.
2. Division of the home-dwelling elderly in community in 1998-99 (the corresponding results in 1990-91 are given in parenthesis) by the number of drugs in use and by difficulties or dependence in ADL, mobility, or IADL.
List of Figures
1. Structure of the study populations in 1990–91 and 1998–99.
2. Mean number of prescription drugs used during seven days prior to the interview by medicine-using home-dwellers aged 64 years or over in community in 1990–91 and 1998–99 by age and sex. The p-values are based on Student´s t-test. p-values * = 0.05, *** = 0.001.
3. After adjustment for sex and age, the mean number of drugs (95% confidence intervals) used by the elderly with or without difficulties or dependence in ADL, mobility, or IADL.
4. After adjustment for sex and age, the mean sedation sum scores (95% confidence intervals) of the elderly with or without difficulties or dependence in ADL, mobility, or IADL.